HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Value of claudin-4 immunostaining in the diagnosis of mesothelioma.

Abstract
Claudin-4 (CL-4) is a tight junction-associated protein that is expressed in most epithelial cells but absent in mesothelial cells. The purpose of this study is to evaluate the utility of CL-4 immunostaining for assisting in the differential diagnosis of mesothelioma. Sixty mesotheliomas (40 epithelioid, 10 biphasic, and 10 sarcomatoid), 185 carcinomas of different origins that can potentially be confused with mesotheliomas, 37 soft-tissue sarcomas, and 5 melanomas were investigated for CL-4 expression. All 60 mesotheliomas were CL-4 negative. In contrast, 169 (91%) of 185 carcinomas expressed this marker. Five of 8 desmoplastic small round cell tumors and the epithelial component of all 5 biphasic synovial sarcomas were CL-4 positive, whereas none of the remaining soft-tissue sarcomas or melanomas expressed this marker. It is concluded that CL-4 is a highly specific and sensitive immunohistochemical marker for assisting in distinguishing epithelioid mesotheliomas from metastatic carcinomas to the serosal membranes.
AuthorsNelson G Ordóñez
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 139 Issue 5 Pg. 611-9 (May 2013) ISSN: 1943-7722 [Electronic] England
PMID23596113 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Claudin-4
Topics
  • Adenocarcinoma (diagnosis, metabolism, secondary)
  • Biomarkers, Tumor (metabolism)
  • Claudin-4 (metabolism)
  • Diagnosis, Differential
  • Epithelioid Cells (metabolism, pathology)
  • Female
  • Humans
  • Male
  • Melanoma (diagnosis, metabolism)
  • Mesothelioma (diagnosis, metabolism)
  • Peritoneal Neoplasms (diagnosis, metabolism, secondary)
  • Pleural Neoplasms (diagnosis, metabolism, secondary)
  • Sarcoma (diagnosis, metabolism)
  • Sarcoma, Synovial (diagnosis, metabolism)
  • Skin Neoplasms (diagnosis, metabolism)
  • Soft Tissue Neoplasms (diagnosis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: